Oncotype cancer testing
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- FA486121D0004
- Awardee
-
Genomic Health, Inc. UEI RHN3L7SBF7J6
- Awarding agency
-
Air Combat Command
Air Force, Department of Defense
- Task orders
- 6 $619,780 obligated
Award facts
- Combined order value
- $619,780 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 60% used
- $1,038,605.62
- Maximum order
- $750,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency awarded a single-award indefinite-delivery contract to Genomic Health, Inc. for Oncotype cancer testing with a ceiling value of $1,038,605.62 on March 16, 2021, with ultimate completion September 15, 2026.
No set-aside was used. Place of performance is Nellis Air Force Base, Nevada. The IDIQ procures Oncotype DX genomic tests that analyze gene expression in breast, prostate, and colon cancers to determine recurrence risk and inform treatment selection for Air Force medical programs.
Period of performance runs March 16, 2021 through September 15, 2026. Delivery orders issued under this IDIQ include a firm fixed-price order for $124,588.79 awarded March 16, 2025 (performance March 16, 2025 through March 15, 2026); an order for $124,588.79 awarded March 16, 2024 (performance March 16, 2024 through March 15, 2025) supporting the 99th Medical Group at Nellis AFB; and an order for $124,588.79 awarded March 16, 2023 (performance March 16, 2023 through March 15, 2024) at North Las Vegas, Nevada. Earlier orders include $141,858.59 awarded March 11, 2022 (completed March 17, 2023) at Las Vegas, Nevada, and $62,259.50 awarded March 18, 2021 (completed March 17, 2022) at Nellis AFB.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract FA486121D0004?
FA486121D0004 was awarded to Genomic Health, Inc. by Air Combat Command (Air Force) on March 16, 2021.
How much is contract FA486121D0004 worth?
Orders under FA486121D0004 have obligated $619,780. FA486121D0004's own ceiling is $1,038,606. A single order can be worth up to $750,000.
How many orders have been placed under contract FA486121D0004?
6 orders have been placed under FA486121D0004, the latest on March 19, 2026.
Which agency awarded contract FA486121D0004?
Air Combat Command (Air Force) awarded FA486121D0004, with funding from Defense Health Agency (Department of Defense).
Who can order from contract FA486121D0004?
FA486121D0004 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract FA486121D0004 competed?
The extent of competition for FA486121D0004 was not competed. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV